Erratum: Macroprolactinemia, like hyperprolactinemia, may promote platelet activation (Endocrine DOI: 10.1007/s12020-009-9304-x);Macroprolactinemia, like hyperprolactinemia, may promote platelet activation

Endocrine

Volumn 37, Issue 2, 2010, Pages 294-300

  Anaforoglu, Inan ^a   Ertorer, Melek Eda ^a   Kozanoglu, Ilknur ^b   Unal, Birsel ^a   Haydardedeoglu, Filiz Eksi ^a   Bakiner, Okan ^a   Bozkirli, Emre ^a   Tutuncu, Neslihan Bascil ^a   Demirag, Nilgun Guvener ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Hyperprolactinemia; Insulin resistance; Macroprolactinemia; Platelet activation

Indexed keywords

MACROGOL; PADGEM PROTEIN; PROLACTIN;

ADULT; AGE; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCRINE DISEASE; FEMALE; HUMAN; HUMAN CELL; HYPERPROLACTINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; MACROPROLACTINEMIA; MENOPAUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; WAIST CIRCUMFERENCE;

EID: 77952096050     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-010-9309-5     Document Type: Erratum

References (30)

1. N Ben-Jonathan ER Hugo TD Brandebourg CR LaPensee 2006 Focus on prolactin as a metabolic hormone Trends Endocrinol. Metab. 17 110 116 10.1016/j.tem.2006.02.005 1:CAS:528:DC%2BD28XjtFOlsLs%3D 16517173
2. R Landgraf MM Landraf-Leurs A Weissmann R Horl K von Werder PC Scriba 1977 Prolactin: a diabetogenic hormone Diabetologia 13 99 104 10.1007/BF00745135 1:CAS:528:DyaE2sXkt1Shtrk%3D 852641
3. MC Foss FJ Paula GM Paccola CE Piccinato 1995 Peripheral glucose metabolism in human hyperprolactinemia Clin. Endocrinol. 43 721 726 10.1111/j.1365-2265.1995.tb00541.x 1:STN:280:DyaK283pslaisg%3D%3D
4. A Mavri MC Alessi I Juhan-Vague 2004 Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases J. Intern. Med. 255 448 456 10.1046/j.1365-2796.2003.01288.x 1:CAS:528:DC%2BD2cXktVOktbw%3D 15049879 (Pubitemid 38446358)
5. R.P. McEver, Leukocyte interactions mediated by P-selectin, in Structure, Function and Regulation of Molecules Involved in Leukocyte Adhesion, ed. by P.E. Lipsky, R. Rothlein, T.K. Kishimoto, R.B. Faanes, C.W. Smith (Springer Verlag, Edinburgh, 1991), pp. 135-150
6. K Gokulakrishnan R Deepa V Mohan DM Gross 2006 Soluble P-selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome-the Chennai Urban Rural Epidemiology Study B Metabolism 55 237 242 10.1016/j.metabol.2005.08.019 1:CAS:528:DC%2BD28XmsFeitg%3D%3D 16423632 (Pubitemid 43098993)
7. D Tschoepe E Driesch B Schwippert HK Nieuwenhuis FA Gries 1995 Exposure of adhesion molecules on activated platelets in patients with newly diagnosed IDDM is not normalized by near-normoglycemia Diabetes 44 890 894 10.2337/diabetes.44.8.890 1:CAS:528:DyaK2MXnsVSnsbY%3D 7542611
8. H Koyama T Maeno S Fukumoto T Shoji T Yamane H Yokoyama M Emoto T Shoji H Tahara M Inaba M Hino A Shioi T Miki Y Nishizawa 2003 Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans Circulation 108 524 529 10.1161/01.CIR.0000081765.88440.51 1:CAS:528:DC%2BD3sXlvVWqsb0%3D 12860908 (Pubitemid 36961164)
9. S Nomura M Suzuki K Katsura GL Xie Y Miyazaki T Miyake H Kido H Kagawa S Fukuhara 1995 Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus Atherosclerosis 116 235 240 10.1016/0021-9150(95)05551-7 1:CAS:528:DyaK2MXmvVegur0%3D 7575778
10. H Wallaschofski M Donné M Eigenthaler B Hentschel R Faber H Stepan M Koksch T Lohmann 2001 PRL as novel potent cofactor for platelet aggregation J. Clin. Endocrinol. Metab. 86 5912 5919 10.1210/jc.86.12.5912 1:CAS:528:DC%2BD3MXptVyks70%3D 11739463 (Pubitemid 33152644)
11. H Wallaschofski A Kobsar M Koksch A Siegemund B Hentschel U Tuschy T Lohmann O Sokolova M Eigenthaler 2003 Prolactin receptor signaling during platelet activation Horm. Metab. Res. 35 228 235 10.1055/s-2003-39059 1:CAS:528:DC%2BD3sXkslais78%3D 12778366 (Pubitemid 36583685)
12. ME Freeman B Kanyicska A Lerant G Nagy 2000 Prolactin: structure, function, and regulation of secretion Physiol. Rev. 80 1523 1631 1:CAS:528:DC%2BD3cXnsVKisLY%3D 11015620
13. J Gibney TP Smith TJ McKenna 2005 Clinical relevance of macroprolactin Clin. Endocrinol. 62 633 643 10.1111/j.1365-2265.2005.02243.x 1:CAS:528:DC%2BD2MXlvFKnsrw%3D (Pubitemid 40825930)
14. H Sadideen R Swaminathan 2006 Macroprolactin: what is it and what is its importance? Int. J. Clin. Pract. 60 457 461 10.1111/j.1368-5031.2006.00732.x 1:CAS:528:DC%2BD28Xltlehs7k%3D 16620360
15. DR Matthews JP Hosker AS Rudenski BA Naylor DF Treacher RC Turner 1985 HOMA; Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 412 419 10.1007/BF00280883 1:CAS:528:DyaL2MXlslKnu7k%3D 3899825 (Pubitemid 15018832)
16. International Diabetes Federation. IDF consensus worldwide definition of the metabolic syndrome (2005), http://www.idf.org/metabolic-syndrome. Accessed 10 Dec 2009
17. AM Suliman TP Smith J Gibney TJ McKenna 2003 Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia Clin. Chem. 49 1504 1509 10.1373/49.9.1504 1:CAS:528:DC%2BD3sXmvVertbw%3D 12928232 (Pubitemid 37011739)
18. H Wallaschofski T Lohmann E Hild A Kobsar A Siegemund E Spilcke-Liss B Hentschel C Stumpf WG Daniel CD Garlichs M Eigenthaler 2006 Enhanced platelet activation by prolactin in patients with ischemic stroke Thromb. Haemost. 96 38 44 1:CAS:528:DC%2BD28XntFeiurw%3D 16807649
19. D Raaz H Wallaschofski C Stumpf A YIlmaz I Cicha L Klinghammer WG Daniel T Lohmann CD Garlichs 2006 Increased prolactin in acute coronary syndromes as putative co-activator of ADP stimulated P-selectin expression Horm. Metab. Res. 38 67 72 10.1055/s-2006-955090 (Pubitemid 44885431)
20. AQ Reuwer R Nieuwland I Fernandez V Goffin CM van Tiel MC Schaaap RJ Berckmans JJ Kastelein MT Twickler 2009 Prolactin does not affect human platelet aggregation or secretion Thromb. Haemost. 101 119 1127
21. M Merten P Thiagarajan 2004 P-selectin in arterial thrombosis Z. Kardiol. 93 855 863 10.1007/s00392-004-0146-5 1:CAS:528:DC%2BD2MXhsFSnug%3D%3D 15568145 (Pubitemid 40064238)
22. AD Blann SK Kadar GY Lip 2003 The adhesion molecule P-selectin and cardiovascular disease Eur. Heart J. 24 2166 2179 10.1016/j.ehj.2003.08.021 1:CAS:528:DC%2BD3sXptlOisrs%3D 14659768 (Pubitemid 37522669)
23. V Leite H Cosby LG Sobrinho MA Fresnoza MA Santos HG Friesen 1992 Characterization of big, big prolactin in patients with hyperprolactinemia Clin. Endocrinol. 37 365 372 10.1111/j.1365-2265.1992.tb02340.x 1:STN:280: DyaK3s7jtVGntg%3D%3D
24. N Hattori C Inagaki 1997 Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunoglobulin G complex J. Clin. Endocrinol. Metabol. 82 3107 3110 10.1210/jc.82.9.3107 1:CAS:528:DyaK2sXlvFemtbs%3D (Pubitemid 27385683)
25. HE Carlson E Markoff DW Lee 1992 On the nature of serum prolactin in two patients with macroprolactinemia Fertil. Steril. 58 78 87 1:STN:280: DyaK38zisVChtw%3D%3D 1624027
26. MN Fahie-Wilson SG Soule 1997 Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol Ann. Clin. Biochem. 34 252 258 1:CAS:528:DyaK2sXktFGrurg%3D 9158821
27. OM Hauache AJ Rocha AC Maia RM Maciel JG Vieira 2002 Screening for macroprolactinaemia and pituitary imaging studies Clin. Endocrinol. 57 327 331 10.1046/j.1365-2265.2002.01586.x 1:CAS:528:DC%2BD38XotVSmsrk%3D (Pubitemid 35013811)
28. KS Vallette RI Morange A Selim G Gunz S Morange A Enjalbert PM Martin P Jaquet T Brue 2002 Macroprolactinemia revisited: a study on 106 patients J. Clin. Endocrinol. Metab. 87 581 588 10.1210/jc.87.2.581 (Pubitemid 34158222)
29. C Mounier J Trouillas B Claustrat R Duthel B Estour 2003 Macroprolactinaemia associated with prolactin adenoma Hum. Reprod. 18 853 857 10.1093/humrep/deg172 1:CAS:528:DC%2BD3sXjtlansbo%3D 12660284 (Pubitemid 36426970)
30. AO Olukoga TL Dornan JW Kane 1999 Three cases of macroprolactinaemia J. R. Soc. Med. 92 342 344 1:STN:280:DC%2BD3c%2Fot1WgsQ%3D%3D 10615271